ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sanofi's Sarclisa cuts death risk in mutiple myeloma pharmatimes
May 13, 2020Sanofi's monoclonal antibody Sarclisa (isatuximab) has hit targets in a late-stage trial, reducing the risk of disease progression or death in patients with relapsed multiple myeloma.
Pharma Sources Insight January 2025
